Sartorius AG (SRT) - Financial and Strategic SWOT Analysis Review
Sartorius AG (SRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Sartorius AG (Sartorius) manufactures and distributes laboratory and process technology equipment. The company’s lab products portfolio includes laboratory instruments, such as pipettes, laboratory water purification systems, weight sets and lab balances. It provides bioprocess solutions for efficient biologic manufacture of medications and vaccines. Sartorius also offers wide range of products for purification, separation and concentration, and solutions for storage and transportation of intermediate and final biological products. The company serves pharmaceutical, biotechnology, chemical, food and beverage industries, and numerous research and educational institutes and laboratories in Germany and across the world. It has manufacturing facilities in Europe, Asia and America. Sartorius is headquartered in Goettingen, Niedersachsen, Germany.
Sartorius AG Key Recent Developments
Apr 24,2018: First-Quarter Figures: Sartorius Starts off Fiscal 2018 Successfully
Jan 31,2018: Sartorius grows significantly again in sales revenue and earnings in 2017 – positive outlook for 2018
Nov 29,2017: Second Sartorius Research Xchange Forum Focuses on Regenerative Medicine and Cell Therapy
Oct 25,2017: Nine-Month Figures for 2017: Sartorius Continues to Grow Profitably in a Challenging Environment
Oct 16,2017: Sartorius Group: Key Figures on 9-Month Business Development in 2017
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Sartorius AG (Sartorius) manufactures and distributes laboratory and process technology equipment. The company’s lab products portfolio includes laboratory instruments, such as pipettes, laboratory water purification systems, weight sets and lab balances. It provides bioprocess solutions for efficient biologic manufacture of medications and vaccines. Sartorius also offers wide range of products for purification, separation and concentration, and solutions for storage and transportation of intermediate and final biological products. The company serves pharmaceutical, biotechnology, chemical, food and beverage industries, and numerous research and educational institutes and laboratories in Germany and across the world. It has manufacturing facilities in Europe, Asia and America. Sartorius is headquartered in Goettingen, Niedersachsen, Germany.
Sartorius AG Key Recent Developments
Apr 24,2018: First-Quarter Figures: Sartorius Starts off Fiscal 2018 Successfully
Jan 31,2018: Sartorius grows significantly again in sales revenue and earnings in 2017 – positive outlook for 2018
Nov 29,2017: Second Sartorius Research Xchange Forum Focuses on Regenerative Medicine and Cell Therapy
Oct 25,2017: Nine-Month Figures for 2017: Sartorius Continues to Grow Profitably in a Challenging Environment
Oct 16,2017: Sartorius Group: Key Figures on 9-Month Business Development in 2017
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
Sartorius AG - Key Facts
Sartorius AG - Key Employees
Sartorius AG - Key Employee Biographies
Sartorius AG - Major Products and Services
Sartorius AG - History
Sartorius AG - Company Statement
Sartorius AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Sartorius AG - Business Description
Business Segment: Bioprocess Solutions
Overview
Performance
Key Stats
Business Segment: Lab Products and Services
Overview
Performance
Key Stats
Geographical Segment: Americas
Target Markets
Performance
Geographical Segment: Asia-Pacific
Target Markets
Performance
Geographical Segment: EMEA
Target Markets
Performance
R&D Overview
Sartorius AG - Corporate Strategy
Sartorius AG - SWOT Analysis
SWOT Analysis - Overview
Sartorius AG - Strengths
Sartorius AG - Weaknesses
Sartorius AG - Opportunities
Sartorius AG - Threats
Sartorius AG - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Sartorius AG, Recent Deals Summary
SECTION 4 – COMPANY’S RECENT DEVELOPMENTS
Apr 24, 2018: First-Quarter Figures: Sartorius Starts off Fiscal 2018 Successfully
Jan 31, 2018: Sartorius grows significantly again in sales revenue and earnings in 2017 – positive outlook for 2018
Nov 29, 2017: Second Sartorius Research Xchange Forum Focuses on Regenerative Medicine and Cell Therapy
Oct 25, 2017: Nine-Month Figures for 2017: Sartorius Continues to Grow Profitably in a Challenging Environment
Oct 16, 2017: Sartorius Group: Key Figures on 9-Month Business Development in 2017
Jul 21, 2017: Business Figures for the First Half of 2017: Sartorius Continues to Grow
Jul 21, 2017: Solid growth at Sartorius Stedim Biotech; profits continue to rise
May 04, 2017: Sartorius Stedim Biotech Launches Chemistry Testing Services
Apr 24, 2017: First-quarter figures: Sartorius starts off 2017 with double-digit growth
Mar 09, 2017: Sartorius appoints Gerry MacKay as Executive Vice President of Marketing, Sales and Services for its Laboratory Division
SECTION 5 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Sartorius AG - Key Facts
Sartorius AG - Key Employees
Sartorius AG - Key Employee Biographies
Sartorius AG - Major Products and Services
Sartorius AG - History
Sartorius AG - Company Statement
Sartorius AG - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
SECTION 2 – COMPANY ANALYSIS
Company Overview
Sartorius AG - Business Description
Business Segment: Bioprocess Solutions
Overview
Performance
Key Stats
Business Segment: Lab Products and Services
Overview
Performance
Key Stats
Geographical Segment: Americas
Target Markets
Performance
Geographical Segment: Asia-Pacific
Target Markets
Performance
Geographical Segment: EMEA
Target Markets
Performance
R&D Overview
Sartorius AG - Corporate Strategy
Sartorius AG - SWOT Analysis
SWOT Analysis - Overview
Sartorius AG - Strengths
Sartorius AG - Weaknesses
Sartorius AG - Opportunities
Sartorius AG - Threats
Sartorius AG - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Sartorius AG, Recent Deals Summary
SECTION 4 – COMPANY’S RECENT DEVELOPMENTS
Apr 24, 2018: First-Quarter Figures: Sartorius Starts off Fiscal 2018 Successfully
Jan 31, 2018: Sartorius grows significantly again in sales revenue and earnings in 2017 – positive outlook for 2018
Nov 29, 2017: Second Sartorius Research Xchange Forum Focuses on Regenerative Medicine and Cell Therapy
Oct 25, 2017: Nine-Month Figures for 2017: Sartorius Continues to Grow Profitably in a Challenging Environment
Oct 16, 2017: Sartorius Group: Key Figures on 9-Month Business Development in 2017
Jul 21, 2017: Business Figures for the First Half of 2017: Sartorius Continues to Grow
Jul 21, 2017: Solid growth at Sartorius Stedim Biotech; profits continue to rise
May 04, 2017: Sartorius Stedim Biotech Launches Chemistry Testing Services
Apr 24, 2017: First-quarter figures: Sartorius starts off 2017 with double-digit growth
Mar 09, 2017: Sartorius appoints Gerry MacKay as Executive Vice President of Marketing, Sales and Services for its Laboratory Division
SECTION 5 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Sartorius AG, Key Facts
Sartorius AG, Key Employees
Sartorius AG, Key Employee Biographies
Sartorius AG, Major Products and Services
Sartorius AG, History
Sartorius AG, Other Locations
Sartorius AG, Subsidiaries
Sartorius AG, Key Competitors
Sartorius AG, Ratios based on current share price
Sartorius AG, Annual Ratios
Sartorius AG, Annual Ratios (Cont.1)
Sartorius AG, Annual Ratios (Cont.2)
Sartorius AG, Interim Ratios
Sartorius AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Sartorius AG, Key Facts
Sartorius AG, Key Employees
Sartorius AG, Key Employee Biographies
Sartorius AG, Major Products and Services
Sartorius AG, History
Sartorius AG, Other Locations
Sartorius AG, Subsidiaries
Sartorius AG, Key Competitors
Sartorius AG, Ratios based on current share price
Sartorius AG, Annual Ratios
Sartorius AG, Annual Ratios (Cont.1)
Sartorius AG, Annual Ratios (Cont.2)
Sartorius AG, Interim Ratios
Sartorius AG, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Sartorius AG, Performance Chart (2013 - 2017)
Sartorius AG, Ratio Charts
COMPANIES MENTIONED
Thermo Fisher Scientific Inc
STRATEC Biomedical AG
Pall Corp
Merck KGaA
General Electric Co
EMD Millipore Corp
Buchi Labortechnik AG
Analytik Jena AG
Sartorius AG, Performance Chart (2013 - 2017)
Sartorius AG, Ratio Charts
COMPANIES MENTIONED
Thermo Fisher Scientific Inc
STRATEC Biomedical AG
Pall Corp
Merck KGaA
General Electric Co
EMD Millipore Corp
Buchi Labortechnik AG
Analytik Jena AG